1
|
D'Amico TA, Bandini LAM, Balch A, Benson AB, Edge SB, Fitzgerald CL, Green RJ, Koh WJ, Kolodziej M, Kumar S, Meropol NJ, Mohler JL, Pfister D, Walters RS, Carlson RW. Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts. J Natl Compr Canc Netw 2021; 18:250-259. [PMID: 32135508 DOI: 10.6004/jnccn.2020.7536] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Accepted: 01/10/2020] [Indexed: 11/17/2022]
Abstract
Although oncology care has evolved, outcome assessment remains a key challenge. Outcome measurement requires identification and adoption of a succinct list of metrics indicative of high-quality cancer care for use within and across healthcare systems. NCCN established an advisory committee, the NCCN Quality and Outcomes Committee, consisting of provider experts from NCCN Member Institutions and other stakeholders, including payers and patient advocacy, community oncology, and health information technology representatives, to review the existing quality landscape and identify contemporary, relevant cancer quality and outcomes measures by reevaluating validated measures for endorsement and proposing new measure concepts to fill crucial gaps. This manuscript reports on 22 measures and concepts; 15 that align with existing measures and 7 that are new.
Collapse
Affiliation(s)
| | | | - Alan Balch
- The National Patient Advocate Foundation, Washington, DC
| | - Al B Benson
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
| | - Stephen B Edge
- Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - C Lyn Fitzgerald
- National Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania
| | | | - Wui-Jin Koh
- National Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania
| | | | - Shaji Kumar
- Mayo Clinic Cancer Center, Rochester, Minnesota
| | | | - James L Mohler
- Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - David Pfister
- Memorial Sloan Kettering Cancer Center, New York, New York; and
| | - Ronald S Walters
- The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Robert W Carlson
- National Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania
| |
Collapse
|
5
|
Nardi EA, Wolfson JA, Rosen ST, Diasio RB, Gerson SL, Parker BA, Alvarnas JC, Levine HA, Fong Y, Weisenburger DD, Fitzgerald CL, Egan M, Stranford S, Carlson RW, Benz EJ. Value, Access, and Cost of Cancer Care Delivery at Academic Cancer Centers. J Natl Compr Canc Netw 2017; 14:837-47. [PMID: 27407124 DOI: 10.6004/jnccn.2016.0088] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2016] [Accepted: 05/24/2016] [Indexed: 11/17/2022]
Abstract
Key challenges facing the oncology community today include access to appropriate, high quality, patient-centered cancer care; defining and delivering high-value care; and rising costs. The National Comprehensive Cancer Network convened a Work Group composed of NCCN Member Institution cancer center directors and their delegates to examine the challenges of access, high costs, and defining and demonstrating value at the academic cancer centers. The group identified key challenges and possible solutions to addressing these issues. The findings and recommendations of the Work Group were then presented at the Value, Access, and Cost of Cancer Care Policy Summit in September 2015 and multi-stakeholder roundtable panel discussions explored these findings and recommendations along with additional items.
Collapse
Affiliation(s)
- Elizabeth A Nardi
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Julie A Wolfson
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Steven T Rosen
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Robert B Diasio
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Stanton L Gerson
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Barbara A Parker
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Joseph C Alvarnas
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Harlan A Levine
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Yuman Fong
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Dennis D Weisenburger
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - C Lyn Fitzgerald
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Maggie Egan
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Sharon Stranford
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Robert W Carlson
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| | - Edward J Benz
- From National Comprehensive Cancer Network, Fort Washington, Pennsylvania; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama; City of Hope Comprehensive Cancer Center, Los Angeles, California; Mayo Clinic Cancer Center, Rochester, Minnesota; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; UC San Diego Moores Cancer Center, La Jolla, California; Patient, City of Hope Comprehensive Cancer Center, Los Angeles, California; and Dana-Farber Cancer Institute, Boston, Massachusetts
| |
Collapse
|